These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14532137)

  • 21. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995.
    Maini RN
    J R Coll Physicians Lond; 1996; 30(4):344-51. PubMed ID: 8875381
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 24. New therapies for rheumatoid arthritis.
    Goldblatt F; Isenberg DA
    Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of rheumatoid arthritis.
    Handa R
    Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
    Schett G; Stach C; Zwerina J; Voll R; Manger B
    Arthritis Rheum; 2008 Oct; 58(10):2936-48. PubMed ID: 18821703
    [No Abstract]   [Full Text] [Related]  

  • 27. [When are "biologics" indicated?].
    MMW Fortschr Med; 2006 Apr; 148(17):10. PubMed ID: 16711479
    [No Abstract]   [Full Text] [Related]  

  • 28. New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
    Scott DL; Cope A
    Ann Rheum Dis; 2009 Jun; 68(6):767-9. PubMed ID: 19435722
    [No Abstract]   [Full Text] [Related]  

  • 29. The rheumatological disease process. Inflammation, immunology, and non-steroidal anti-inflammatory drugs. Proceedings of an international symposium. London, England, April 28-29, 1983.
    Inflammation; 1984 Jun; 8 Suppl():S1-154. PubMed ID: 6480067
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeted therapy in rheumatoid arthritis.
    Köller MD
    Wien Med Wochenschr; 2006 Jan; 156(1-2):53-60. PubMed ID: 16465614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Golimumab (simponi) for inflammatory arthritis.
    Med Lett Drugs Ther; 2009 Jul; 51(1316):55-6. PubMed ID: 19590489
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting interleukin-1 in the treatment of rheumatoid arthritis.
    Dayer JM; Bresnihan B
    Arthritis Rheum; 2002 Mar; 46(3):574-8. PubMed ID: 11920390
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of biologics for rheumatoid arthritis tempered by concerns over safety, cost.
    Pressman Lovinger S
    JAMA; 2003 Jun; 289(24):3229-30. PubMed ID: 12824197
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
    Taylor PC
    Curr Opin Pharmacol; 2010 Jun; 10(3):308-15. PubMed ID: 20172761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in use of immunomodulatory agents--a rheumatology perspective.
    Her M; Kavanaugh A
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):363-8. PubMed ID: 25895821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
    Siebert S; Tsoukas A; Robertson J; McInnes I
    Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Dentener MA; Wouters EF
    N Engl J Med; 2006 Nov; 355(19):2047-8; author reply 2048. PubMed ID: 17099951
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor necrosis factor alpha blockers and metastases: comment on the article by Setoguchi et al.
    McGrath H
    Arthritis Rheum; 2007 Feb; 56(2):695-6; author reply 696. PubMed ID: 17265509
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.